BioNexus Gene Lab names CFO Chong Set Fui in initial beneficial ownership filing
BGLC•Initial Form 3 filing for CFO
BioNexus Gene Lab filed an initial Form 3 for CFO Chong Set Fui, dated June 17, 2025.
Related News
Certain Blackrock Closed-End Funds Announce Estimated Sources Of Distributions
BLK•
Blue Owl Capital Continued To Experience Elevated Redemption Requests In Some Blue Owl Managed Non-Traded Bdcs In Q2 - SEC Filing
OWL•
US, Israel planning to bombard energy-related targets in Iran, CBS reports
XLE•
aTyr Pharma - Co And Kyorin Terminate Collaboration Agreement Effective July 30, 2026
ATYR•
Paul Mueller Q2 FY26 net income slips 1.81% to USD 11.42 million
MUEL•